Responsible AI
in Clinical Trials
in Clinical Trials
Stay informed with AI industry insiders! Register for the 2nd annual virtual summit on October 8 and 9, 2024.
Returning and New Powerhouses:
Microsoft, MongoDB, PwC & Halloran
Microsoft, MongoDB, PwC & Halloran
Building on last year's success, these industry leaders have already secured speaker slots for this year's summit. Don't miss their invaluable insights.
If your organization is interested in contributing to the dialogue as a speaker of panelist, please get in touch with us.
From Bots to Agents:
The Evolution of AI in Clinical Trials
The Evolution of AI in Clinical Trials
As AI technology evolves from simple bots to sophisticated agents, the potential for its application in clinical trials expands significantly. This summit will explore the journey of AI development and its implications for the clinical trials industry.
Like last year, we are approaching speakers to ensure an impressive line-up for the 2024 summit. Below, you will find the esteemed speakers from last year's event. Each speaker, panelist, and moderator will bring expertise and insights, promising enriching discussions that probe profoundly into the nuances of responsible AI.
Danny Goh
Nexus FrontierTech
Meghan Conroy
CAPTUREPROOF
Wole Moses
Microsoft
Francesc Mateu
MongoDB
Prof Kai Eckert
Mannheim University of AS
Moe Alsumidaie
CliniBiz
Nechama Katan
Big Pharma
Adam Baumgart
Alcedo Consulting
Hendrik A. Reese
PwC Germany
Linda Bunschoten
Cyntegrity
Johann Proeve
Cyntegrity
Keith Dorricott
MyRBQM Academy
Event Details
Dates
October 8 & 9, 2024
Time
15:00 - 17:30 CEST | 9:00 AM - 11:30 AM EDT
Format
Virtual, 2 webinars of 2.5 hours each
DAY 1 | TUESDAY, OCTOBER 8
- Introduction & Welcome Remarks - Event objectives & the importance of AI in clinical trials
- AI as an Assistant - What are the practical applications of AI as an assistant, and how can it be supervised effectively to ensure accurate and reliable outcomes?
- Bias and Fairness - How can we identify and mitigate biases in AI algorithms used in clinical trials, and what steps can be taken to ensure these models are fair and unbiased?
- Change Management (Stakeholder and Panel Discussion) - What strategies can be employed to manage change and foster acceptance of AI in clinical trials, and how can organizations involve stakeholders early in the AI implementation process?
- Q/A & Closing Remarks
DAY 2 | WEDNESDAY, OCTOBER 9
- Recap Day 1 - Insights & Observations
- Real-World Applications - What are some successful case studies of AI implementation in clinical trials, and what lessons can be learned from these to guide future AI projects?
- Latest Legislations Concerning AI - What are the latest regulatory updates and guidelines for AI in clinical trials, and how can organizations navigate the regulatory landscape to ensure compliance while leveraging AI?
- Future Trends (Stakeholder and Panel Discussion) - What are the emerging trends in AI technology that could impact clinical trials, and how can organizations stay ahead of the curve and prepare for future AI advancements?
- Q/A & Closing Remarks - Summary & next steps for Responsible AI
Who Should Join the Dialogue?
Directors and Senior Managers specializing in: Clinical Operations & Study Management, Innovation & New Technologies, Clinical Monitoring & Site Management, Project & Program Management
Heads of Therapeutic Areas and Medical Affairs
Functional Leads in Data Management and Biostatistics
Compliance and Quality Assurance Officers
Regulatory Affairs Executives
We're on the verge of a new era in clinical trials, where AI processes data and understands human emotions and preferences.
Let's leverage AI's power to create a future where technology and humanity collaborate to improve healthcare outcomes.
Artem Andrianov, PhD
CEO & Founder of Cyntegrity
Got 10 Minutes?
How do you see the future of AI in clinical trials? Help us understand the impact of AI in clinical trials.
AI-Augmented RBQM Solutions
©2024 Cyntegrity - All Rights Reserved
